Form 4: Anterix CLO Gena Ashe Reports Stock Withholding
Statement of Changes in Beneficial Ownership
Anterix Inc. Chief Legal Officer Gena L. Ashe reported the withholding of 1,028 shares to satisfy tax obligations related to restricted stock unit vesting.
Summary
- Gena L. Ashe, Chief Legal Officer and Corporate Secretary of Anterix Inc., executed a transaction on May 18, 2026.
- The transaction involved the withholding of 1,028 shares of common stock by the issuer.
- The shares were withheld at a price of $57.06 per share.
- The purpose of the transaction was to satisfy tax withholding obligations associated with the vesting of restricted stock units.
- Following this transaction, the reporting person maintains a direct beneficial ownership of 12,338 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard administrative tax settlement rather than a discretionary sale of stock.
Positives
- The transaction reflects the vesting of equity-based compensation, aligning the executive's interests with long-term shareholder value.
Negatives
- The transaction resulted in a minor reduction in the reporting person's total share count.
Risks
- None identified; this is a routine administrative transaction related to tax obligations.
Future Outlook
Not applicable; this is a retrospective disclosure of a completed transaction.
Industry Context
StockSavvy.ai notes that routine tax withholding transactions by corporate officers are standard administrative procedures and do not typically signal a change in management sentiment regarding the company's future performance.
Comparison to Industry Standards
- The transaction follows standard corporate governance practices for equity compensation settlement in the technology and telecommunications sectors.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a routine tax settlement.
Next Steps
- None
Key Dates
| Date | Description |
|---|---|
| 05/18/2026 | Date of the transaction involving the withholding of shares. |
| 05/20/2026 | Date the Form 4 was signed and filed. |
Keywords
Anterix, ATEX, Insider Trading, Form 4, Equity Compensation, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.